Phospho-STAT1 (Ser727) Antibody [F23C16]

Catalog No.: F2358

    Application: Reactivity:

    当該製品は品切れ状态で、ごメールアドレスを教えていただければ、在庫があると、メールで顧客様に伝えます。

    代表番号: 045-509-1970|電子メール:sales@selleck.co.jp

    使用情報

    Dilution
    1:10000
    1:1000-1:100000
    Application
    WB, FCM
    Source
    Rabbit Monoclonal Antibody
    Reactivity
    Human
    Storage Buffer
    PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
    Storage (from the date of receipt)
    -20°C (avoid freeze-thaw cycles), 2 years
    Predicted MW
    87 kDa

    Datasheet & SDS

    生物学的記述

    Specificity
    Phospho-STAT1 (Ser727) Antibody [F23C16] detects endogenous levels of total STAT1 protein only when it is Phosphorylated at Ser727.
    Clone
    F23C16
    Synonym(s)
    Signal transducer and activator of transcription 1-alpha/beta; Transcription factor ISGF-3 components p91/p84; STAT1
    Background
    Phospho-STAT1 (Ser727) is the serine-phosphorylated form of STAT1 at residue Ser727, a modification that plays a pivotal role in regulating STAT1’s transcriptional activity within interferon (IFN) signaling. STAT1, a latent transcription factor, contains several domains: an N-terminal oligomerization domain, a coiled-coil domain, a DNA-binding domain, an SH2 domain for dimerization via Tyr701 phosphorylation, and a C-terminal transactivation domain (TAD) harboring the Ser727 phosphorylation motif (PMSP), which is targeted by MAPKs such as p38. Phosphorylation at Ser727 occurs downstream of IFN-α/γ, cellular stress, or LPS, dependent on prior Tyr701 activation, and enhances STAT1’s interaction with coactivators like CBP/p300. This modification is essential for maximal transcriptional activation of IFN-responsive genes: it augments promoter recruitment and chromatin binding, supporting antiviral responses, macrophage activation, and inflammation. Aberrant Ser727 phosphorylation is linked to tumorigenesis and impaired IFN signaling by disrupting normal STAT1 activity.
    References

    技術サポート

    ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

    Handling Instructions

    他に質問がある場合は、お気軽にお問い合わせください。

    * 必須

    大学・企業名を記入してください
    名前を記入してください
    電子メール・アドレスを記入してください 有効なメールアドレスを入力してください
    お問い合わせ内容をご入力ください